Enjoy complimentary customisation on priority with our Enterprise License!
The inhaled nitric oxide market share is expected to increase by USD 353.77 million from 2021 to 2026, at a CAGR of 8.6%.
This inhaled nitric oxide market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers inhaled nitric oxide market segmentation by application (neonatal respiratory treatment, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and others) and geography (North America, APAC, Europe, South America, and Middle East and Africa). The inhaled nitric oxide market report also offers information on several market vendors, including Bellerophon Therapeutics Inc., Berkeley Life and L2G North America Inc., Beyond Air Inc., Cigna Corp., Circassia Group PLC, Geno Pharmaceuticals Pvt. Ltd., Getinge AB, Halma Plc, HumanN, Inspiration Healthcare Group Plc, L Air Liquide SA, Linde Plc, Mallinckrodt Plc, Merck KGaA, Moda Health Plan Inc., Nu Med Plus Inc., Uniscience Group, and VERO Biotech among others.
Download Report Sample to Unlock the Inhaled Nitric Oxide Market Size for the Forecast Period and Other Important Statistics
The use of inhaled nitric oxide in cardiac surgeries is notably driving the inhaled nitric oxide market growth, although factors such as adverse effects of inhaled nitric oxide may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the inhaled nitric oxide industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Inhaled Nitric Oxide Market Driver
The use of inhaled nitric oxide in cardiac surgeries is one of the key drivers fueling the inhaled nitric oxide market growth. Inhaled nitric oxide gas is commonly used to treat inflammation and neuronal transmission. It is now more frequently used to treat hypoxemic respiratory failure. In addition to this, cardiothoracic operations have been treated with inhaled nitric oxide gas. Nitric oxide gas quickly mixes with hemoglobin, reducing surgical problems and supporting the maintenance of systemic blood pressure. Patients with prior cardiothoracic operations are managed with inhaled nitric oxide gas. Nitric oxide inhalation has also been shown to be the best method for managing cardiothoracic operations. Thus such use of inhaled nitric oxide in cardiac surgeries will drive market growth during the forecast period.
Key Inhaled Nitric Oxide Market Trend
The rise in the number of patients with COPD is one of the key inhaled nitric oxide market trends propelling the market growth. The factors such as old age and the presence of rare genetic disorders will contribute to the rising prevalence of COPD and usually appear after 40 years of age. As per The Hindu Centre for Politics and Public Policy, the share of the elderly population aged above 65 years is expected to increase from 9.3% in 2020 to around 16% in 2050 globally. Hence, the growth of the global geriatric population will further increase the number of people with the risk of developing COPD. Likewise, rare genetic conditions such as deficiency of alpha-1 antitrypsin are expected to predispose people to an increased risk of COPD. Such an increased case will drive the growth of the market during the forecast period.
Key Inhaled Nitric Oxide Market Challenge
Adverse effects of inhaled nitric oxide is one of the key factors limiting the inhaled nitric oxide market growth. The toxicological effects of nitric oxide are difficult to distinguish from its pharmacological characteristics when it is inhaled. For instance, increased cellular cyclic guanosine monophosphate (cGMP) plays a role in how inhaled nitric oxide causes the lungs to dilate. However, increased cGMP might obstruct regular cellular proliferation. Nitric oxide has also been demonstrated to result in mutagenic deoxyribonucleic acid (DNA) base changes or strand breakage. It can quickly combine with oxygen in the lungs to create nitrogen dioxide, which is a strong irritant to the lungs. These adverse effects will limit the market growth during the forecast period.
This inhaled nitric oxide market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global inhaled nitric oxide market as a part of the global specialty chemicals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the inhaled nitric oxide market during the forecast period.
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
This statistical study of the inhaled nitric oxide market encompasses successful business strategies deployed by the key vendors. The inhaled nitric oxide market is fragmented and the vendors are deploying growth strategies such as focusing on R&D activities to develop advanced, innovative products and strengthen their product portfolios to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The inhaled nitric oxide market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the inhaled nitric oxide market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request PDF Sample now!
31% of the market’s growth will originate from North America during the forecast period. The US is the key market for the inhaled nitric oxide market in North America. Market growth in this region will be faster than the growth of the market in Middle East and Africa.
The rise in the prevalence of respiratory diseases will facilitate the inhaled nitric oxide market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
In 2020, the COVID-19 pandemic increased the demand for inhaled nitric oxide therapy. Inhaled nitric oxide is utilized to treat pulmonary hypertension, ARDS, and other respiratory illnesses, while numerous ongoing randomized clinical trials are being carried out to look into the function of inhaled nitric oxide in COVID-19 patients. It is also being used with encouraging results in the patient group in several ongoing clinical trials as a therapy for COVID-19. Such factors may propel the market growth during the forecast period.
To gain further insights on the market contribution of various segments Request PDF Sample
The inhaled nitric oxide market share growth by the neonatal respiratory treatment segment will be significant during the forecast period. Neonatal respiratory treatment is the largest segment in the global inhaled nitric oxide market. This is due to the increase in the prevalence of respiratory treatment in neonates, which has driven the demand for inhaled nitric oxide. Additionally, an increase in the prevalence of diseases in the newborns, such as persistent pulmonary hypertension and neonatal hypoxic respiratory failure (HRF), contributes to the growth of the global inhaled nitric oxide market during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the inhaled nitric oxide market size and actionable market insights on post COVID-19 impact on each segment.
Inhaled Nitric Oxide Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Decelerate at a CAGR of 8.6% |
Market growth 2022-2026 |
$ 353.77 million |
Market structure |
Fragmented |
YoY growth (%) |
10.21 |
Regional analysis |
North America, APAC, Europe, South America, and Middle East and Africa |
Performing market contribution |
North America at 31% |
Key consumer countries |
US, China, India, Germany, and UK |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Bellerophon Therapeutics Inc., Berkeley Life and L2G North America Inc., Beyond Air Inc., Cigna Corp., Circassia Group PLC, Geno Pharmaceuticals Pvt. Ltd., Getinge AB, Halma Plc, HumanN, Inspiration Healthcare Group Plc, L Air Liquide SA, Linde Plc, Mallinckrodt Plc, Merck KGaA, Moda Health Plan Inc., Nu Med Plus Inc., Uniscience Group, and VERO Biotech |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Application
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.